The present disclosure provides an OCT imaging system having a variety of advantages. In particular, the OCT system of the present disclosure may provide a more intuitive interface, more efficient usage of controls, and a greater ability to view OCT imaging data.
A system for reducing artifacts produced in images using an optica! probe system is provided. The artifacts are reduced by reducing power of secondary beam paths produced by non-Fresnel reflections by at ieast one of absorption, scattering and rejection of the secondary beam paths.
The present disclosure provides an OCT imaging system to reduce or eliminate frequency-domain aliasing artifacts. The frequency is shifted using a carrier frequency to define a sampling range substantially centered on the carrier frequency. An image of the sample is generated from a displayed imaging range that consists of a subset of the frequencies within the sampling range.
Esophageal cancer is one of the fastest growing cancer's in America and Pam Sain has been raising money to to raise awareness and get in the fight. After losing her father to esophageal cancer, she began the Taste of Point Orlando event to raise money. The proceeds from those events have gone to purchase new endoscopic technology to help diagnose esophageal cancer more quickly. Something Pam believes could have saved her father. Pam herself was one of the first patients to have an endoscopy with the new device as she is an acid reflux sufferer. To learn more visit ...
NinePoint Medical, Inc. is a medical device company integrating multiple technologies to streamline patient care. NinePoint is initially developing novel products for use during minimally invasive procedures such as endoscopy and laparoscopy to provide enhanced diagnostic capabilities and improve outcomes.
NinePoint Medical is the first medical device company that Third Rock Ventures has seeded and launched, and we are optimistic that the company's unique positioning will successfully change the treatment paradigm in a market with significant unmet needs.Mark Levin in NinePoint Medical Completes $33 Million Series A Financing to Develop Innovative Broad-Based Medical Platform for in vivo Pathology Devices
I am excited to join NinePoint Medical's board and continue to build on my experience working with startups composed of great people, great technology, great market opportunities and, most importantly, the potential to make a major impact. NinePoint Medical is at an exciting stage, and its technology platform has the potential to greatly improve the diagnostic and treatment options available to the medical community.Eric A. Swanson in NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors
I am excited to join NinePoint Medical’s board and continue to build on my experience working with startups composed of great people, great technology, great market opportunities and, most importantly, the potential to make a major impact. NinePoint Medical is at an exciting stage, and its technology platform has the potential to greatly improve the diagnostic and treatment options available to the medical community...I look forward to working closely with the rest of the board and management team to move NinePoint’s innovative technology forward in development.Eric A. Swanson in NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors